SCHEMBL30977478

SCHEMBL30977478

COc1ccc(CN(Cc2ccc(OC)cc2)c2nc(OC)c(CC(F)F)c(OC)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
MAPT P10636 2/20 0.43
PIK3CA P42336 1/20 0.42
ALDH1A1 P00352 3/20 0.39
PRUNE1 Q86TP1 1/20 0.38
CYP2D6 P10635 4/20 0.37
CYP1A2 P05177 3/20 0.37
SLC6A4 P31645 2/20 0.37
TSHR P16473 2/20 0.37
CYP2C19 P33261 2/20 0.37
MEN1 O00255 1/20 0.37
CHRM2 P08172 1/20 0.37
CYP3A4 P08684 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA2A P08913 1/20 0.37
DRD1 P21728 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HRH1 P35367 1/20 0.37
OPRM1 P35372 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26977759 0.88 LMNA (0.40) LMNAMAPTPIK3CAALDH1A1PRUNE1
SCHEMBL27036960 0.83 LMNA (0.40) LMNAMAPTPIK3CAALDH1A1PRUNE1
SCHEMBL26977745 0.83 PRUNE1 (0.41) LMNAMAPTPIK3CAALDH1A1PRUNE1
SCHEMBL26978014 0.82 LMNA (0.42) LMNAMAPTPIK3CAALDH1A1CYP2D6
SCHEMBL26977362 0.82 LMNA (0.44) LMNAMAPTPIK3CAALDH1A1PRUNE1
SCHEMBL26977718 0.81 LMNA (0.43) LMNAMAPTPIK3CAALDH1A1PRUNE1
SCHEMBL30977477 0.80 PIK3CA (0.44) LMNAMAPTPIK3CAALDH1A1PRUNE1
SCHEMBL26977735 0.79 LMNA (0.48) LMNAMAPTPIK3CAALDH1A1PRUNE1
SCHEMBL26978069 0.79 LMNA (0.48) LMNAMAPTPIK3CAALDH1A1PRUNE1
SCHEMBL12935065 0.79 LMNA (0.48) LMNAMAPTPIK3CAALDH1A1PRUNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619402-A1 GPR17 MODULATORS AND USES THEREOF Myrobalan Therapeutics, Inc. (US) 2025-09-24 EP disclosed
CN-119613397-A N-heteroaromatic ring-3-sulfonamide compounds and use thereof for preparing GPR17 receptor inhibitors 迈巴制药(南京)有限公司 2025-03-14 CN disclosed
WO-2024104462-A1 GPR17 MODULATORS AND USES THEREOF MYROBALAN THERAPEUTICS NANJING CO. LTD (CN) 2024-05-23 WO disclosed